Arcus Biosciences, Inc. (NYSE: RCUS ) develops immunotherapies for lung, gastrointestinal (GI), kidney, pancreatic, and colorectal cancers. The company discovers and designs small molecules and antibodies optimized for combination therapies. Then, it aims for accelerated development through a deep understanding of cancer mechanisms and strategic collaborations with My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, ...